{"id":"https://openalex.org/W2407855180","doi":null,"title":"Effekter av omega-3-fettsyrer p\u00e5 blodplater og interaksjon med warfarin","display_name":"Effekter av omega-3-fettsyrer p\u00e5 blodplater og interaksjon med warfarin","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2407855180","mag":"2407855180"},"language":"no","primary_location":{"id":"pmh:oai:www.duo.uio.no:10852/38919","doi":null,"is_oa":true,"landing_page_url":"http://urn.nb.no/URN:NBN:no-42646","pdf_url":"http://hdl.handle.net/10852/38919","source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/masterThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10852/38919","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014833935","display_name":"Kevin Thanh Nguyen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kevin Thanh Nguyen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5014833935"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":1.0},{"id":"https://openalex.org/keywords/fish-oil","display_name":"fish oil","score":0.8809999823570251},{"id":"https://openalex.org/keywords/platelets","display_name":"platelets","score":0.7639999985694885},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9279999732971191},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7260000109672546},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.8830000162124634},{"id":"https://openalex.org/keywords/docosahexaenoic-acid","display_name":"docosahexaenoic acid","score":0.9020000100135803},{"id":"https://openalex.org/keywords/eicosapentaenoic-acid","display_name":"eicosapentaenoic acid","score":1.0},{"id":"https://openalex.org/keywords/cox-1-inhibition","display_name":"COX-1 inhibition","score":0.9359999895095825},{"id":"https://openalex.org/keywords/thromboxane-a2","display_name":"thromboxane A2","score":0.9190000295639038},{"id":"https://openalex.org/keywords/bleeding-time","display_name":"bleeding time","score":0.7580000162124634},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.753000020980835},{"id":"https://openalex.org/keywords/hemostasis","display_name":"hemostasis","score":0.6589999794960022},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.5220000147819519},{"id":"https://openalex.org/keywords/international-normalized-ratio","display_name":"international normalized ratio","score":0.6489999890327454},{"id":"https://openalex.org/keywords/ischemic-heart-disease-prevention","display_name":"ischemic heart disease prevention","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C2779557605","wikidata":"https://www.wikidata.org/wiki/Q9890","display_name":"Omega","level":2,"score":0.610435962677002},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.42346665263175964},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3933797776699066},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.18408942222595215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18106332421302795},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.07430076599121094},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:www.duo.uio.no:10852/38919","doi":null,"is_oa":true,"landing_page_url":"http://urn.nb.no/URN:NBN:no-42646","pdf_url":"http://hdl.handle.net/10852/38919","source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/masterThesis"},{"id":"mag:2407855180","doi":null,"is_oa":false,"landing_page_url":"https://www.duo.uio.no/bitstream/handle/10852/38919/Warfarin-og-omega.pdf?sequence=1","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:www.duo.uio.no:10852/38919","doi":null,"is_oa":true,"landing_page_url":"http://urn.nb.no/URN:NBN:no-42646","pdf_url":"http://hdl.handle.net/10852/38919","source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/masterThesis"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2407855180.pdf","grobid_xml":"https://content.openalex.org/works/W2407855180.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W237879491","https://openalex.org/W1534222671","https://openalex.org/W1987393255","https://openalex.org/W1991147447","https://openalex.org/W1991354189","https://openalex.org/W1991619890","https://openalex.org/W2008873477","https://openalex.org/W2033689648","https://openalex.org/W2049069835","https://openalex.org/W2066812214","https://openalex.org/W2082951744","https://openalex.org/W2083542511","https://openalex.org/W2086927336","https://openalex.org/W2128264631","https://openalex.org/W2134070386","https://openalex.org/W2135981842","https://openalex.org/W2148186684","https://openalex.org/W2148190114","https://openalex.org/W2148516429","https://openalex.org/W2153216875","https://openalex.org/W2499034224","https://openalex.org/W2548670201"],"related_works":["https://openalex.org/W2588420470","https://openalex.org/W2009423007","https://openalex.org/W2130716261","https://openalex.org/W4402751928","https://openalex.org/W3039194404","https://openalex.org/W2065311490","https://openalex.org/W1984203340","https://openalex.org/W1976756817","https://openalex.org/W2083542511","https://openalex.org/W2943177582"],"abstract_inverted_index":{"M\u00e5lsetning:":[0],"M\u00e5lsetningen":[1],"med":[2,20,74,147,158,193],"oppgaven":[3],"var":[4],"\u00e5":[5,31,122,186],"foreta":[6],"en":[7,46,113,138,199,207],"litteraturstudie":[8],"som":[9,129,154],"ser":[10,119],"p\u00e5":[11,15,180],"effekter":[12],"av":[13,24,132,141,165,190,202],"omega-3-fettsyrer":[14,44,156,168,182,191,211],"blodplater":[16,109],"og":[17,26,37,52,63,83,96,110,126,134,149,169,212],"mulig":[18],"interaksjon":[19,209],"warfarin":[21,159,170,194],"Bakgrunn:":[22],"Inntak":[23,189],"fiskeoljer":[25,62],"sj\u00f8mat":[27],"er":[28,56,205],"kjent":[29],"for":[30,34],"redusere":[32],"risikoen":[33],"iskemiske":[35],"hjertesykdommer,":[36],"derfor":[38],"har":[39,45,160,171],"det":[40,206],"v\u00e6rt":[41,161],"foresl\u00e5tt":[42],"at":[43,101,124,181],"antitrombotisk":[47],"effekt.":[48],"Omega-3-fettsyrene":[49],"dokosaheksaensyre":[50],"(DHA,C22:6n-3)":[51],"eikosapentaensyre":[53],"(EPA,":[54],"C20:5n-3)":[55],"sannsynligvis":[57],"de":[58],"aktive":[59],"komponentene":[60],"i":[61,72,106,108],"sj\u00f8mat.":[64],"Metoder:":[65],"Det":[66],"ble":[67],"gjort":[68],"et":[69],"systematisk":[70],"s\u00f8k":[71],"PubMed":[73],"f\u00f8lgende":[75],"s\u00f8kestrategi:":[76],"Fish":[77,84],"oils":[78],"AND":[79,81,86],"Platelets":[80],"Effects":[82],"Oils":[85],"Warfarin":[87],".":[88],"Resultater:":[89],"Resultater":[90],"fra":[91],"in":[92,94],"vivo,":[93],"vitro":[95],"ex":[97],"vivo":[98],"studier":[99,164],"viser":[100],"omega-3-":[102],"fettsyrer":[103],"blir":[104],"inkorporert":[105],"cellemembranen":[107],"f\u00f8rer":[111,136],"til":[112,121,137,143],"redusert":[114,139],"plateaggregasjon.":[115],"Den":[116],"viktigste":[117],"mekanismen":[118],"ut":[120],"v\u00e6re":[123],"EPA":[125],"DHA":[127],"virker":[128],"kompetitive":[130],"inhibitorer":[131],"COX-1-enzymet,":[133],"dette":[135],"omdannelse":[140],"arakidonsyre":[142],"tromboksan":[144],"A2.":[145],"Episoder":[146],"bl\u00f8dninger":[148],"forh\u00f8yet":[150],"INR":[151],"hos":[152],"pasienter":[153],"tar":[155],"sammen":[157,192],"rapportert,":[162],"men":[163],"interaksjoner":[166],"mellom":[167,210],"vist":[172],"motstridende":[173],"resultater.":[174],"Konklusjon:":[175],"De":[176],"foreliggende":[177],"data":[178],"tyder":[179],"\u00f8ker":[183],"bl\u00f8dningstiden":[184],"ved":[185],"hemme":[187],"plateaggregering.":[188],"vil":[195],"dermed":[196],"kunne":[197],"gi":[198],"forsterkende":[200],"hemming":[201],"hemostasen.":[203],"Sannsynligvis":[204],"farmakodynamisk":[208],"warfarin.":[213]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}